Corrigendum to “A triple crosslinked micelle-hydrogel lacrimal implant for localized and prolonged therapy of glaucoma” [Eur. J. Pharm. Biopharm. 185 (2023) 44–54]
Fields of Study & Subjects
Advanced Drug Delivery Systems
Glaucoma and retinal disorders
Hydrogels: synthesis
properties
applications
Publication details
- Journal / source
- European Journal of Pharmaceutics and Biopharmaceutics
- Volume
- 222
- Pages
- 115019–115019
- Publication date
- 11 February 2026
- Language
- EN